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investigated for molecular mechanisms
that underlie and explain drug adverse
events. This investigation will use and
contribute to the biomedical Linked
Open Data [3]. 
The PractiKPharma consortium com-
prises four academic partners: two com-
puter science laboratories, the LORIA
(Laboratoire Lorrain de Recherche en
Informatique et ses Applications,
Nancy, France) in Nancy, the LIRMM
(Laboratoire d’Informatique, de Robot-
ique et de Microélectronique de Mont-
pellier, France) in Montpellier; and two
University Hospitals, the HEGP (The
Georges Pompidou European Hospital,
Assistance Publique – Hôpitaux de Paris
(AP-HP), France) in Paris, specialized
in EHRs management and pharmacoge-
nomics, and the CHU Saint-Etienne
(University Hospital (CHU) of Saint
Etienne, France), specialized in pharma-
covigilance.  
PractiKPharma will have impacts both
in computer science and biomedicine,
including:
• the development of novel methods
for knowledge extraction from text
and EHRs; 
• enabling multilingual semantic anno-
tation of EHRs; 
• methods for representing and com-
paring SOTA and observational
knowledge; 
• a database that maps genotypes to
quantitative traits to facilitate the
study of PGx with EHRs; 
• the completion and connection of
Linked Open Data related to PGx; 
• methods for hypothesizing on mecha-
nisms of adverse events and validated
PGx knowledge units. 
Overall, the final goal of
PractiKPharma is to provide clinicians
with actionable PGx knowledge to
establish guidelines that when imple-
mented in personalized medicine will
reduce drug adverse events, and
improve the quality of clinical care.
The PractiKPharma consortium will
hire two PhD students, two post-docs,
one pharmacist and one research engi-
neer to contribute to the project. In addi-
tion, PractiKPharma will foster collabo-
ration and dissemination throughout the
EU to take into consideration EHRs of
various populations and to establish
international projects.
Link:
PractiKPharma project:
http://practikpharma.loria.fr
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Special Theme: Tackling Big Data in the Life Sciences  
In collaboration with the two academic
hospitals in Amsterdam our research
group at CWI develops mathematical
models to help unravel the growth of
capillaries, the smallest blood vessels in
our body. The building blocks of capil-
laries are endothelial cells, a cell type
that covers the inner walls of all our
blood vessels, and the extracellular
matrix, a scaffolding of structural pro-
tein fibres that keeps cells and tissues
together.  Together with auxiliary cell
types, the endothelial cells remodel the
extracellular matrix to form blood ves-
sels, and they secrete new matrix pro-
teins to strengthen themselves.  Our col-
laborators in the academic hospitals
mimic angiogenesis, by culturing
endothelial cells inside gels of extracel-
lular matrix proteins. In response to
growth factors and other signals in the
extracellular matrix, the cells aggregate
and organize into networks of blood-
vessel-like sprouts. 
The goal of our mathematical modelling
project is to find out the rules that cells
must follow in order to form biological
structures, such as networks and blood
vessel sprouts. Our models describe the
behaviour of the individual cells: how
they move, the  strength of their adhe-
sion to adjacent cells, their shape, and
their response to signals from adjacent
cells and from the extracellular matrix.
If we understand how cells must behave
to form a new blood vessel, perhaps
then we can also learn how to use phar-
maceuticals to fine-tune that behaviour
so the cells do what we want them to do.
If we could do this for a relatively
simple mechanism like blood vessel
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Throughout our lives our blood vessels form new capillaries whose insufficient or excessive growth is
a key factor in disease. During wound healing, insufficient growth of capillaries limits the supply of
oxygen and nutrients to the new tissue.  Tumours often attract capillaries, giving them their own
blood supply and a route for further spread over the body.  With the help of biological and medical
colleagues our team develops mathematical models that recapitulate how cells can construct new
blood vessels. These models are helping us to develop new ideas about how to stimulate or stop the
growth of new blood vessels.
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growth, this might give us new ideas for
other steps in the development of multi-
cellular organisms.  
In an initial set of models, we assumed
that cells attract one another via chem-
ical signals. It is not difficult to see that
this rule will not suffice for forming net-
works: It simply makes the cells accu-
mulate into small aggregates. To our
surprise, however, the same rules could
make cells form networks if the cells
had an elongated shape. This makes the
aggregates stretch out, and connect to
adjacent aggregates such that a network
emerges. But the cells did not need to be
elongated: if instead the cells became
insensitive to the attractive signals at
the positions of their membranes where
they touched one another, they also
organized into networks. 
Our recent work employs these two
models to gain greater insight into the
mechanisms of angiogenesis. Our initial
models ignored that in actual angiogen-
esis, two types of endothelial cells are
involved: the tip cells that lead the
sprouts, and the stalk cells that form the
body of the sprout by ``stalking’’ the tip
cells. Recent experimental observations
have shown that one of the stalk cells
regularly replaces the tip cell, much like
migratory birds take turns in the leading
position in front of the “V”.  Much
experimental work has focused on the
molecular regulation of this phenom-
enon. We discovered that such tip cell
overtaking occurs naturally in our
models, as a side effect of the cell
behaviours responsible for sprouting.
We integrated the molecular networks
responsible for tip-stalk cell differentia-
tion inside each of the simulated
endothelial cells, and could reproduce
many of the experimental observations
that were taken as evidence for the
molecular regulation of tip cell over-
taking [1] (Figure 1). Thus our models
suggest that the molecular networks
may be there to ensure that the cell that
happens to end up in front takes on the
role of leader. 
Despite the insights we acquired from
our initial models, they ignored a key
component in angiogenesis. Most cells
in our body are surrounded by a fibrous
or jelly material called the extracellular
matrix, or “matrix” for short. It has a
structural role – the matrix gives our
bones their strength and keeps cells
together – but recently it has become
clear that it also acts as a medium for
cell-cell signalling. Cells deposit
growth factors into the matrix, which
other cells find later on, as if cells leave
“written” notes for one another. Also,
cells apply mechanical forces on the
matrix, and they respond to forces they
feel in their surroundings. In this way
the matrix can relay mechanical signals
from cell to cell. Recently we have
started to explore how such mechanical
cell-cell signalling can help coordinate
the behaviour of endothelial cells. We
extended our models of angiogenesis
with a finite-element model of the
extracellular matrix [2]. The endothelial
cells apply contractile forces on the
matrix. The finite-element model then
calculates the strains resulting from
these forces, which, in turn, affects the
membrane movements of the cells.
These relatively few assumptions repro-
duced observations on how matrix stiff-
ness determines the shape of single
cells, how adjacent cells interact with
one another, and how cells form vas-
cular-like sprouts and networks
(Figure 1).
Now that our models have given us
some first clues on how cells build
blood vessels, we are taking these
insights back to our experimental col-
laborators.  The basic understanding of
angiogenesis captured by our models is
employed in more specific models of
diseases, e.g., diabetic retinopathy.  The
models give the experimentalists new
ideas on how to “nudge” the endothelial
cells to do, or not do, what they want.
Of course, biology still has many sur-
prises in store for us; rarely do experi-
ments agree with our models in every
detail. Frustrating as this may sound,
this is actually when our models
become most useful. Mismatches
between model and experiment high-
light the areas in vascular biology that
are not yet fully understood.
Links:
Group website:
http://biomodel.project.cwi.nl
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Figure 1: Models of blood vessel growth. (A-C) Growth of a sprout and “overtaking” of the tip
cell. Colour scale indicates state of the embedded genetic network models; red: high expression
of tip cell marker Dll4; blue: low Dll4 expression. Figure modified from Ref. [1]. (D-F). Model
of mechanical interaction between cells and extracellular matrix. Due to the cell-matrix
interactions, the cell elongated (D), they align with adjacent cells (E), and they form networks
(F).  Figure by EGR, reprinted in modified form from “Merks. ITM Web of Conferences, in
press” according to the model described in Ref. [2]. Figures A-F reproduced under the terms of
the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/).
